🇺🇸 MRK — Merck & Co., Inc.

Healthcare Compra
← Volver

Precio actual

150,33 USD

Máx. histórico

156,92

10 días

Caída desde máximo

-4,20%

Rango 52 semanas

77,58 – 156,92

Variación hoy

-1,32%

Cierre anterior

152,34

Rango de hoy

150,09 – 152,22

Volumen hoy

4.298.143

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
122,22 (puede no estar actualizado)
Dividend yield
2,23% (puede no estar actualizado)
Precio objetivo analistas
148,73 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 1 día
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,3600 USD · Yield: 2,24%
Fecha de pago Importe por participación
13/06/2011 0,3626 USD
11/03/2011 0,3626 USD
13/12/2010 0,3626 USD
13/09/2010 0,3626 USD
11/06/2010 0,3626 USD
11/03/2010 0,3626 USD
11/12/2009 0,3626 USD
02/09/2009 0,3626 USD
04/06/2009 0,3626 USD
04/03/2009 0,3626 USD
03/12/2008 0,3626 USD
03/09/2008 0,3626 USD
04/06/2008 0,3626 USD
05/03/2008 0,3626 USD
05/12/2007 0,3626 USD
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
27/08/2021 76,81 76,97 76,17 76,30 -0,35% 1,04% 6.010.000
26/08/2021 77,11 77,32 76,51 76,57 -0,65% 1,05% 6.640.400
25/08/2021 77,81 77,81 76,40 77,07 -0,84% 1,81% 7.045.800
24/08/2021 78,27 78,27 77,54 77,72 -0,84% 0,93% 8.698.100
23/08/2021 79,11 79,23 78,34 78,38 -0,38% 1,13% 6.492.600
20/08/2021 78,53 79,20 78,22 78,68 +0,28% 1,25% 6.284.200
19/08/2021 77,71 79,14 77,71 78,46 +0,86% 1,84% 8.865.400
18/08/2021 78,88 79,07 77,75 77,79 -1,32% 1,67% 7.459.100
17/08/2021 77,90 79,06 77,83 78,83 +1,15% 1,58% 10.311.600
16/08/2021 76,73 78,01 76,64 77,93 +1,58% 1,79% 9.368.400
13/08/2021 76,36 76,77 76,22 76,72 +0,89% 0,72% 6.810.400
12/08/2021 75,12 76,06 75,06 76,04 +1,10% 1,33% 6.077.100
11/08/2021 75,58 75,77 75,14 75,21 +0,03% 0,83% 6.952.200
10/08/2021 75,15 75,36 74,82 75,19 -0,17% 0,72% 11.243.100
09/08/2021 75,85 76,22 75,00 75,32 -0,16% 1,61% 7.867.000
06/08/2021 75,62 75,66 74,99 75,44 -0,20% 0,89% 8.670.700
05/08/2021 75,52 75,69 74,93 75,59 +0,15% 1,01% 8.701.600
04/08/2021 76,49 76,49 75,46 75,48 -1,22% 1,35% 10.893.400
03/08/2021 76,36 76,81 76,19 76,41 +0,30% 0,81% 9.952.400
02/08/2021 76,93 77,26 76,14 76,18 -0,90% 1,46% 9.083.400
30/07/2021 77,12 77,76 76,77 76,87 -0,08% 1,28% 13.004.500
29/07/2021 77,55 77,92 76,81 76,93 -1,79% 1,43% 11.583.000
28/07/2021 77,86 78,67 77,47 78,33 +0,62% 1,54% 11.037.900
27/07/2021 77,17 78,13 76,74 77,85 +0,79% 1,80% 8.136.000
26/07/2021 77,46 77,61 76,96 77,24 -0,39% 0,84% 5.071.800
23/07/2021 76,80 77,68 76,73 77,54 +1,32% 1,24% 6.560.800
22/07/2021 76,60 76,79 76,08 76,53 +0,18% 0,93% 8.708.900
21/07/2021 76,32 76,46 75,64 76,39 +0,29% 1,07% 7.429.300
20/07/2021 77,19 78,13 75,95 76,17 -1,14% 2,82% 11.627.600
19/07/2021 77,81 78,34 76,15 77,05 -1,24% 2,81% 9.830.600